会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 99. 发明授权
    • Compositions and methods for inducing cytotoxic T lymphocyte responses by immunization with protein antigens
    • 用蛋白质抗原免疫诱导细胞毒性T淋巴细胞反应的组合物和方法
    • US06328972B1
    • 2001-12-11
    • US08425679
    • 1995-04-18
    • Kenneth L. Rock
    • Kenneth L. Rock
    • A61K39385
    • A61K9/167A61K39/00A61K2039/60Y02A50/466Y10S977/802Y10S977/803Y10S977/915Y10S977/917Y10S977/918Y10S977/92
    • The invention provides compositions and methods for inducing MHC class I-restricted cytotoxic T lymphocyte responses in a mammalian host by immunization with non-replicating protein antigens. The compositions of the invention comprise a two-component complex including a particle component, which is not a prokaryotic or eukaryotic cell, or a micellar, multimicellar, or liposome vesicle composed of detergents and/or lipids, ranging in size from about 10 nm to about 50 &mgr;m, and a non-replicating protein antigen. The non-replicating protein antigen is attached to the particle component through a covalent or non-covalent association to form particulate protein antigen complexes and the complexes are administered to a mammalian host in conjunction with a pharmaceutically acceptable excipient, in a CTL-stimulatory amount. The invention also provides non-replicating vaccines and methods of vaccinating a mammalian host for CTL immunity.
    • 本发明提供了通过用非复制蛋白抗原免疫在哺乳动物宿主中诱导MHC I类限制性细胞毒性T淋巴细胞应答的组合物和方法。 本发明的组合物包含双组分复合物,其包括不是原核或真核细胞的颗粒组分,或由洗涤剂和/或脂质组成的胶束,多片或脂质体囊泡,其尺寸范围为约10nm至 约50微克,以及非复制蛋白质抗原。 非复制蛋白质抗原通过共价或非共价缔合连接到颗粒组分上以形成颗粒蛋白抗原复合物,并且将复合物以CTL刺激量与药学上可接受的赋形剂联合施用于哺乳动物宿主。 本发明还提供了非复制疫苗和用于CTL免疫接种哺乳动物宿主的方法。